USD 16.8
(-3.17%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -2.82 Million | -15.79 Million | 7.18 Million | 10.66 Million | 4.41 Million | -1.89 Million |
Net Income | -51.28 Million | -24.41 Million | -19.43 Million | -11.2 Million | -7.11 Million | -13.79 Million |
Depreciation & Amortization | 6.19 Million | 5.84 Million | 5.07 Million | 3.35 Million | 2.18 Million | 1.34 Million |
Deferred income taxes | -40.39 Million | - | -2.51 Million | 105 Thousand | 576 Thousand | - |
Stock-based compensation | 24.09 Million | 28.98 Million | 30.02 Million | 24.17 Million | 12.72 Million | 7.12 Million |
Change in working capital | -1.68 Million | -22.75 Million | -6.13 Million | -7.54 Million | -3.81 Million | 3.08 Million |
Other non-cash items | 60.23 Million | -3.45 Million | 179 Thousand | 1.77 Million | -135 Thousand | 351 Thousand |
Investing Cash Flow | 9.35 Million | -4.29 Million | -18.81 Million | -18.75 Million | -2.97 Million | -3.66 Million |
Investments in PPE | -3.84 Million | -4.29 Million | -2.86 Million | -3.82 Million | -2.97 Million | -3.66 Million |
Acquisitions | 13.19 Million | - | -15.95 Million | -14.93 Million | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 13.19 Million | -4.29 Million | -2.86 Million | -3.82 Million | -2.97 Million | -3.66 Million |
Financing Cash Flow | 577 Thousand | 15.84 Million | 3.61 Million | 4.9 Million | 2.98 Million | 44.83 Million |
Debt repayment | - | - | - | - | - | -27.35 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | -402 Thousand | -100 Thousand | - | - | - | - |
Common Stock Issuance | 979 Thousand | 15.94 Million | 3.61 Million | 4.9 Million | 2.98 Million | 52.31 Million |
Other Financing Activities | -402 Thousand | 15.94 Million | 3.61 Million | 4.9 Million | 2.98 Million | 19.87 Million |
Accounts receivables | 8.21 Million | 5.36 Million | 10.51 Million | -13.97 Million | -15.23 Million | -2.93 Million |
Accounts payables | -13.41 Million | 1.12 Million | -3.96 Million | 9.3 Million | 6.83 Million | 4.93 Million |
Inventory | 1.00 | - | -12.9 Million | -3.24 Million | 4.51 Million | 461 Thousand |
Other working capital | 3.51 Million | -29.24 Million | 227 Thousand | 368 Thousand | 61 Thousand | 619 Thousand |
Cash at beginning of period | 30.83 Million | 35.1 Million | 43.12 Million | 46.3 Million | 41.88 Million | 2.61 Million |
Cash at end of period | 37.95 Million | 30.83 Million | 35.1 Million | 43.12 Million | 46.3 Million | 41.88 Million |
Capital Expenditure | -3.84 Million | -4.29 Million | -2.86 Million | -3.82 Million | -2.97 Million | -3.66 Million |
Effect of forex changes on cash | 18 Thousand | -27 Thousand | -6000.00 | -7000.00 | - | - |
Net cash flow / Change in cash | 7.12 Million | -4.26 Million | -8.01 Million | -3.18 Million | 4.42 Million | 39.27 Million |
Free Cash Flow | -6.66 Million | -20.08 Million | 4.32 Million | 6.84 Million | 1.43 Million | -5.56 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 11.55 Million | 6.4 Million | 1.9 Million | -6.34 Million | -51.28 Million | -29.21 Million |
Depreciation & Amortization | 1.61 Million | 1.23 Million | 1.26 Million | 1.07 Million | 6.19 Million | 2.25 Million |
Deferred income taxes | - | - | - | -9.39 Million | -40.39 Million | 2.28 Million |
Stock-based compensation | 5.44 Million | 5.34 Million | 4.51 Million | 4.81 Million | 24.09 Million | 5.64 Million |
Change in working capital | 4.92 Million | -591 Thousand | 2.73 Million | -372 Thousand | -1.68 Million | -2.54 Million |
Other non-cash items | 5.51 Million | 8.92 Million | 8.31 Million | 9.43 Million | 60.23 Million | 17.43 Million |
Investing Cash Flow | -1.48 Million | -852 Thousand | -770 Thousand | -852 Thousand | 9.35 Million | 12.22 Million |
Investments in PPE | -1.48 Million | -852 Thousand | -770 Thousand | -852 Thousand | -3.84 Million | -966 Thousand |
Acquisitions | - | - | - | -13.19 Million | 13.19 Million | 13.19 Million |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -1.48 Million | - | -770 Thousand | 9.35 Million | 13.19 Million | 13.19 Million |
Financing Cash Flow | -219 Thousand | 772 Thousand | 999 Thousand | 536 Thousand | 577 Thousand | -67 Thousand |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | 843 Thousand | -414 Thousand | -429 Thousand | -103 Thousand | -402 Thousand | -67 Thousand |
Common Stock Issuance | 288 Thousand | 1.18 Million | 1.42 Million | 639 Thousand | 979 Thousand | - |
Other Financing Activities | -219 Thousand | -414 Thousand | -429 Thousand | -103 Thousand | -402 Thousand | -67 Thousand |
Accounts receivables | -219 Thousand | -9.73 Million | -17.12 Million | 952 Thousand | 8.21 Million | -63 Thousand |
Accounts payables | 5.22 Million | 8.61 Million | 15.86 Million | -3.38 Million | -13.41 Million | -2.21 Million |
Inventory | - | - | - | 1.55 Million | 1.00 | -354 Thousand |
Other working capital | -72 Thousand | 531 Thousand | 3.99 Million | 2.05 Million | 3.51 Million | 92 Thousand |
Cash at beginning of period | 60.91 Million | 48.62 Million | 37.95 Million | 39.04 Million | 30.83 Million | 31.04 Million |
Cash at end of period | 82.84 Million | 60.91 Million | 48.62 Million | 37.95 Million | 37.95 Million | 39.04 Million |
Capital Expenditure | -1.48 Million | -852 Thousand | -770 Thousand | -852 Thousand | -3.84 Million | -966 Thousand |
Effect of forex changes on cash | 16 Thousand | 1000.00 | -5000.00 | 15 Thousand | 18 Thousand | -13 Thousand |
Net cash flow / Change in cash | 21.92 Million | 12.29 Million | 10.66 Million | -1.09 Million | 7.12 Million | 8 Million |
Free Cash Flow | 22.12 Million | 11.52 Million | 9.67 Million | -1.64 Million | -6.66 Million | -5.11 Million |
SUVIDHAA
CLS
JYOTHYLAB
BRS
BIOVF
KIRLOSBROS